71 related articles for article (PubMed ID: 29149413)
1. Role of extracellular vesicles in castration-resistant prostate cancer.
Liao C; Huang Z; Liu J; Deng M; Wang L; Chen Y; Li J; Zhao J; Luo X; Zhu J; Wu Q; Fu W; Sun B; Zheng J
Crit Rev Oncol Hematol; 2024 May; 197():104348. PubMed ID: 38588967
[TBL] [Abstract][Full Text] [Related]
2. DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer.
Le TK; Cherif C; Omabe K; Paris C; Lannes F; Audebert S; Baudelet E; Hamimed M; Barbolosi D; Finetti P; Bastide C; Fazli L; Gleave M; Bertucci F; Taïeb D; Rocchi P
Mol Ther; 2023 Feb; 31(2):471-486. PubMed ID: 35965411
[TBL] [Abstract][Full Text] [Related]
3. Nanotherapeutic Approach to Delivery of Chemo- and Gene Therapy for Organ-Confined and Advanced Castration-Resistant Prostate Cancer.
Sharma S; Mahajan SD; Chevli K; Schwartz SA; Aalinkeel R
Crit Rev Ther Drug Carrier Syst; 2023; 40(4):69-100. PubMed ID: 37075068
[TBL] [Abstract][Full Text] [Related]
4. Castration-resistant prostate cancer: potential targets and therapies.
Parray A; Siddique HR; Nanda S; Konety BR; Saleem M
Biologics; 2012; 6():267-76. PubMed ID: 22956858
[TBL] [Abstract][Full Text] [Related]
5. [Hope for a new treatment for castration-resistant prostate cancer].
Terzic J; Metzger D
Med Sci (Paris); 2023 Oct; 39(10):709-711. PubMed ID: 37943128
[No Abstract] [Full Text] [Related]
6. Comparative Pathobiology of Canine and Human Prostate Cancer: State of the Art and Future Directions.
Nascente EP; Amorim RL; Fonseca-Alves CE; de Moura VMBD
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681707
[TBL] [Abstract][Full Text] [Related]
7. Novel Cure for Phthisis, and a New Operation of Castration.
N Am Medchir Rev; 1858 Sep; 2(5):972. PubMed ID: 38080316
[No Abstract] [Full Text] [Related]
8. Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer.
Sponziello M; Benvenuti S; Gentile A; Pecce V; Rosignolo F; Virzì AR; Milan M; Comoglio PM; Londin E; Fortina P; Barnabei A; Appetecchia M; Marandino F; Russo D; Filetti S; Durante C; Verrienti A
Hum Mutat; 2018 Mar; 39(3):371-377. PubMed ID: 29219214
[TBL] [Abstract][Full Text] [Related]
9. Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer.
Ferrari N; Granata I; Capaia M; Piccirillo M; Guarracino MR; Venè R; Brizzolara A; Petretto A; Inglese E; Morini M; Astigiano S; Amaro AA; Boccardo F; Balbi C; Barboro P
Cell Commun Signal; 2017 Dec; 15(1):51. PubMed ID: 29216878
[TBL] [Abstract][Full Text] [Related]
10. Translationally controlled tumor protein: the mediator promoting cancer invasion and migration and its potential clinical prospects.
Gao J; Ma Y; Yang G; Li G
J Zhejiang Univ Sci B; 2022 Aug; 23(8):642-654. PubMed ID: 35953758
[TBL] [Abstract][Full Text] [Related]
11. miR-145-5p inhibits the proliferation of glioma stem cells by targeting translationally controlled tumor protein.
Zhang Q; Cheng Z; Shi L; Mao G
J Cancer; 2022; 13(5):1490-1500. PubMed ID: 35371310
[TBL] [Abstract][Full Text] [Related]
12. Nanovectorization of Prostate Cancer Treatment Strategies: A New Approach to Improved Outcomes.
Omabe K; Paris C; Lannes F; Taïeb D; Rocchi P
Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33919150
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer.
Sicard G; Paris C; Giacometti S; Rodallec A; Ciccolini J; Rocchi P; Fanciullino R
Pharmaceutics; 2020 Nov; 12(12):. PubMed ID: 33260460
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of TCTP in Biological Processes and Diseases.
Bommer UA; Telerman A
Cells; 2020 Jul; 9(7):. PubMed ID: 32645936
[TBL] [Abstract][Full Text] [Related]
15. DHA Affects Microtubule Dynamics Through Reduction of Phospho-TCTP Levels and Enhances the Antiproliferative Effect of T-DM1 in Trastuzumab-Resistant HER2-Positive Breast Cancer Cell Lines.
D'Amico S; Krasnowska EK; Manni I; Toietta G; Baldari S; Piaggio G; Ranalli M; Gambacurta A; Vernieri C; Di Giacinto F; Bernassola F; de Braud F; Lucibello M
Cells; 2020 May; 9(5):. PubMed ID: 32438775
[TBL] [Abstract][Full Text] [Related]
16. TCTP Has a Crucial Role in the Different Stages of Prostate Cancer Malignant Progression.
Baylot V; Karaki S; Rocchi P
Results Probl Cell Differ; 2017; 64():255-261. PubMed ID: 29149413
[TBL] [Abstract][Full Text] [Related]
17. Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer.
Baylot V; Katsogiannou M; Andrieu C; Taieb D; Acunzo J; Giusiano S; Fazli L; Gleave M; Garrido C; Rocchi P
Mol Ther; 2012 Dec; 20(12):2244-56. PubMed ID: 22893039
[TBL] [Abstract][Full Text] [Related]
18. Lipid-oligonucleotide conjugates improve cellular uptake and efficiency of TCTP-antisense in castration-resistant prostate cancer.
Karaki S; Benizri S; Mejías R; Baylot V; Branger N; Nguyen T; Vialet B; Oumzil K; Barthélémy P; Rocchi P
J Control Release; 2017 Jul; 258():1-9. PubMed ID: 28472637
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
